INSIDER · CIK 1880129
Kenney Christopher John
Chief Medical Officer at Xenon Pharmaceuticals Inc. (XENE)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$426KSold on the market
1Companies
Aug 31, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 202621:59 | Aug 28, 2026 | XENEXenon Pharmaceuticals Inc. | Chief Medical Officer | S · Sell10b5-1 | $60.25 | −7,068 | 2 | -100% | −$426K |